<p>Global prevalence of neurocognitive impairment in each treatment group and by presence of comorbidities.</p
<p>Comparisons of the Frascati Criteria and Global Deficit Scores to define neurocognitive impairmen...
<p>Performance of three definitions of cognitive impairment in a simulated population with a 10% pre...
Objective: The total scores of the ADAS-cog, MMSE and CAMCOG, comprising various cognitive tasks, ar...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores ±SD, in the patients enrolled ...
Prevalence, incidence and persistence of significant neuropsychiatric symptoms (NPS) at each assessm...
<p>The cognitive impairment prevalence percentages for each of the seven Latin American and Caribbea...
Prevalence of major and mild neurocognitive disorder by demographic characteristics using orientatio...
<p>Proportion of Global YLDs and YLLs Attributable to Mental, Neurological, and Substance Use Disord...
<p>Distribution of prevalence of severe neurodevelopmental impairment per 1,000 children in select c...
Prevalence of major and mild neurocognitive disorder by demographic characteristics: Results from LA...
Changes in criteria and differences in populations studied and methodology have produced a wide rang...
In the aggregate, neurologic, psychiatric, and devel-opmental disorders (NPDDs) are the largest cont...
The overview is based on modern Russian and global data on the prevalence, genetic and environmental...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores±SD, in the patients enrolled (...
<p>Number of patients showing any impairment on neuropsychological assessments.</p
<p>Comparisons of the Frascati Criteria and Global Deficit Scores to define neurocognitive impairmen...
<p>Performance of three definitions of cognitive impairment in a simulated population with a 10% pre...
Objective: The total scores of the ADAS-cog, MMSE and CAMCOG, comprising various cognitive tasks, ar...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores ±SD, in the patients enrolled ...
Prevalence, incidence and persistence of significant neuropsychiatric symptoms (NPS) at each assessm...
<p>The cognitive impairment prevalence percentages for each of the seven Latin American and Caribbea...
Prevalence of major and mild neurocognitive disorder by demographic characteristics using orientatio...
<p>Proportion of Global YLDs and YLLs Attributable to Mental, Neurological, and Substance Use Disord...
<p>Distribution of prevalence of severe neurodevelopmental impairment per 1,000 children in select c...
Prevalence of major and mild neurocognitive disorder by demographic characteristics: Results from LA...
Changes in criteria and differences in populations studied and methodology have produced a wide rang...
In the aggregate, neurologic, psychiatric, and devel-opmental disorders (NPDDs) are the largest cont...
The overview is based on modern Russian and global data on the prevalence, genetic and environmental...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores±SD, in the patients enrolled (...
<p>Number of patients showing any impairment on neuropsychological assessments.</p
<p>Comparisons of the Frascati Criteria and Global Deficit Scores to define neurocognitive impairmen...
<p>Performance of three definitions of cognitive impairment in a simulated population with a 10% pre...
Objective: The total scores of the ADAS-cog, MMSE and CAMCOG, comprising various cognitive tasks, ar...